Literature DB >> 743943

Preparation, purification, and stability of high specific activity 125I-labeled thyronines.

N Kochupillai, R S Yalow.   

Abstract

A modified chloramine-T method is described for the preparation of several radioiodothyronines by an exchange reaction, which results in low specific activity preparations, or by an addition reaction, which yields radioiodothyronines with specific activities up to 7 mCi/microgram. Purification by paper chromatography is shown to be more convenient than by LH-20 chromatography and provides better resolution among the various thyronines. Radioiodothyronines with only a single iodine atom in the outer (3,5,3'-triiodothyronine and 3,3'-diiodothyronine) are stable for several months when stored in organic solvents. The least stable radioiodothyronines are those with two 125I atoms in the outer ring (3,3',5'-triiodothyronine (rT3) produced from 3-iodothyronine and thyroxine (T4) from 3,5-diiodothyronine). The stability of rT3 and T4 stored in human plasma at 4 C is much greater than when stored in buffer at the same pH. The use of high specific activity [125I]rT3 has permitted the development of a radioimmunoassay with a sensitivity of 1 pg rT3/ml incubation volume.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743943     DOI: 10.1210/endo-102-1-128

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Iodothyronine 5'-deiodinase activity as an early event of prenatal brown-fat differentiation in bovine development.

Authors:  M Giralt; L Casteilla; O Viñas; T Mampel; R Iglesias; J Robelin; F Villarroya
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  Iodothyronine 5'-deiodinase activity and thyroid hormone content in brown adipose tissue during the breeding cycle of the rat.

Authors:  O Viñas; M Giralt; M J Obregón; R Iglesias; F Villarroya; T Mampel
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

3.  Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.

Authors:  J E Silva; M B Gordon; F R Crantz; J L Leonard; P R Larsen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Role of L-thyroxine in nuclear thyroid hormone receptor occupancy and growth hormone production in cultured GC cells.

Authors:  Y Halperin; L E Shapiro; M I Surks
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  Direct assessment of brown adipose tissue as a site of systemic tri-iodothyronine production in the rat.

Authors:  J A Fernandez; T Mampel; F Villarroya; R Iglesias
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

6.  Interrelationships among thyroxine, growth hormone, and the sympathetic nervous system in the regulation of 5'-iodothyronine deiodinase in rat brown adipose tissue.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis.

Authors:  E M Kaptein; W J Robinson; D A Grieb; J T Nicoloff
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Production rates and turnover of triiodothyronine in rat-developing cerebral cortex and cerebellum. Responses to hypothyroidism.

Authors:  J E Silva; P S Matthews
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver.

Authors:  A S Jennings; D C Ferguson; R D Utiger
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

10.  Ontogenesis of iodothyronine-5'-deiodinase. Induction of 5'-deiodinating activity by insulin, glucocorticoid, and thyroxine in cultured fetal mouse liver.

Authors:  K Sato; H Mimura; D C Han; T Tsushima; K Shizume
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.